Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30falsefalseNo description of principal activityfalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2023-07-053true 14981224 2023-07-04 14981224 2023-07-05 2024-06-30 14981224 2022-07-01 2023-07-04 14981224 2024-06-30 14981224 c:Director1 2023-07-05 2024-06-30 14981224 c:Director1 2024-06-30 14981224 c:Director2 2023-07-05 2024-06-30 14981224 c:Director2 2024-06-30 14981224 c:RegisteredOffice 2023-07-05 2024-06-30 14981224 d:CurrentFinancialInstruments 2024-06-30 14981224 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 14981224 d:ShareCapital 2024-06-30 14981224 d:RetainedEarningsAccumulatedLosses 2024-06-30 14981224 c:FRS102 2023-07-05 2024-06-30 14981224 c:AuditExempt-NoAccountantsReport 2023-07-05 2024-06-30 14981224 c:FullAccounts 2023-07-05 2024-06-30 14981224 c:PrivateLimitedCompanyLtd 2023-07-05 2024-06-30 14981224 e:PoundSterling 2023-07-05 2024-06-30 iso4217:GBP xbrli:pure
Company registration number: 14981224







UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
30 JUNE 2024


NOVARI HEALTH UK LIMITED
































      





img18b5.png                        

 


NOVARI HEALTH UK LIMITED
 


 
COMPANY INFORMATION


Directors
J Lott (appointed 5 July 2023)
J Sinclair (appointed 5 July 2023)




Registered number
14981224



Registered office
The Walbrook Building
25 Walbrook

London

EC4N 8AF




Accountants
Menzies LLP
Chartered Accountants

Lynton House

7-12 Tavistock Square

London

WC1H 9LT





 


NOVARI HEALTH UK LIMITED
 



CONTENTS



Page
Statement of financial position
1
Notes to the financial statements
2 - 4


 


NOVARI HEALTH UK LIMITED
REGISTERED NUMBER:14981224



STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2024

2024
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
32,743

Cash at bank and in hand
  
5,796

  
38,539

Creditors: amounts falling due within one year
 5 
(28,401)

Net current assets
  
 
 
10,138

Total assets less current liabilities
  
10,138

  

Net assets
  
10,138


Capital and reserves
  

Called up share capital 
  
1

Profit and loss account
  
10,137

  
10,138


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J Lott
Director

Date: 12 August 2024

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 


NOVARI HEALTH UK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024

1.


General information

Novari Health UK Limited is a private company, limited by shares, registered in England and Wales, with company registration number 14981224. The registered office is stated on the company information page. There is no principal place of business.
The company was incorporated and began trading on 5 July 2023. The accounts cover the short period ending 30 June 2024

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 2

 


NOVARI HEALTH UK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees




The average monthly number of employees, including directors, during the period was 3.

Page 3

 


NOVARI HEALTH UK LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024

4.


Debtors

2024
£


Other debtors
19,810

Prepayments and accrued income
12,933

32,743



5.


Creditors: Amounts falling due within one year

2024
£

Trade creditors
20,988

Corporation tax
2,663

Accruals and deferred income
4,750

28,401



6.


Controlling party

The ultimate controlling party is Novari Health Inc located at 1473 John Counter, Boulevard Suite 401, Kingston, Canada, K7M 8Z6.

 
Page 4